Search Result "TMEM106B."
The Development of Drug Therapies for Frontotemporal Dementia Caused by Progranulin Mutations
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 3 Year: 2015
Author(s): Louis De Muynck,Philip Van Damme
Doi: 10.2174/9781681080680115030007
Neurodegenerative Diseases: A Multidisciplinary Approach
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 30 Year: 2021 Page: 3305-3336
Author(s): Pilar Marcos-Rabal,JoaquÃn González-Fuentes,LucÃa Castro-Vázquez,María V. Lozano,Virginia RodrÃguez-Robledo,Manuel J. Santander-Ortega,Jorge Selva-Clemente,Noemà Villaseca-González,MarÃa del Mar Arroyo-Jiménez
High-dose Everolimus May Induce Pro-inflammatory/Fibrotic TranscriptomicChanges in Bronchial Epithelial Cells from Cystic FibrosisPatients
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 18 Issue: 2 Year: 2021 Page: 91-106
Author(s): Simona Granata,Alberto Verlato,Valentina Masola,Amedeo Carraro,Gloria Santoro,Gianluigi Zaza
Disease-Modifying Therapies in Frontotemporal Lobar Degeneration
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 1008-1020
Author(s): B. Bigni, E. Premi, A. Pilotto, A. Padovani, B. Borroni
COVID-19 and Alzheimer's Disease: Neuroinflammation, OxidativeStress, Ferroptosis, and Mechanisms Involved
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 35 Year: 2023 Page: 3993-4031
Author(s): Alicia B. Pomilio,Arturo A. Vitale,Alberto J. Lazarowski